Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 75 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

75 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Oct. 23, 2024 CVS P 35 $56.85 $1,990 85 Indirect +70.00% Acquired 52.1% (price as of 2026-10-02)
Oct. 2, 2024 CVS P 10 $62.24 $622 50 Indirect +25.00% Acquired 38.9% (price as of 2026-10-02)
Sept. 9, 2024 CVS P 35 $56.47 $1,976 40 Indirect +700.00% Acquired 53.1% (price as of 2026-10-02)
Dec. 29, 2023 MCD S 2,750 $295.84 $813,560 15,207 Direct -15.31% Disposed -21.6% (price as of 2026-10-02)
Dec. 1, 2023 MCD S 687 $283.25 $194,593 17,957 Direct -3.68% Disposed -18.1% (price as of 2026-10-02)
Nov. 1, 2023 MCD S 687 $263.00 $180,681 18,644 Direct -3.55% Disposed -11.8% (price as of 2026-10-02)
Oct. 2, 2023 MCD S 688 $262.00 $180,256 19,331 Direct -3.44% Disposed -11.5% (price as of 2026-10-02)
Sept. 1, 2023 MCD S 688 $282.54 $194,388 20,019 Direct -3.32% Disposed -17.9% (price as of 2026-10-02)
Feb. 13, 2019 BA S 2,916 $410.84 $1,198,009 24,791 Direct -10.52% Disposed -52.9% (price as of 2026-10-02)
May 3, 2018 BA S 1,132 $329.84 $373,379 24,416 Direct -4.43% Disposed -41.3% (price as of 2026-10-02)
Aug. 1, 2017 BA S 2,871 $240.95 $691,767 23,582 Direct -10.85% Disposed -19.7% (price as of 2026-10-02)
July 31, 2017 BA S 1,346 $242.72 $326,701 26,453 Direct -4.84% Disposed -20.3% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
March 31, 2026 CVS Stock Option [F3] Common Stock (64,670) $71.82 March 31, 2036 64,670 Acquired
April 1, 2025 CVS Stock Option [F2] Common Stock (49,906) $67.98 April 1, 2035 49,906 Acquired
May 28, 2024 MCD Dividend Equivalent Rights Common Stock · May 28, 2024 630 Disposed
May 28, 2024 MCD Restricted Stock Units Common Stock · May 28, 2024 6,623 Disposed
Feb. 16, 2024 MCD Dividend Equivalent Rights Common Stock · Feb. 16, 2024 894 Disposed
Feb. 16, 2024 MCD Restricted Stock Units Common Stock · Feb. 16, 2024 12,956 Disposed
Feb. 12, 2024 MCD Restricted Stock Units Common Stock · Feb. 16, 2024 6,940 Acquired
Feb. 12, 2024 MCD Options (Right to Buy) Common Stock (25,076) $289.44 Feb. 12, 2034 25,076 Acquired
May 28, 2023 MCD Dividend Equivalent Rights Common Stock · May 28, 2023 513 Disposed
May 28, 2023 MCD Restricted Stock Units Common Stock · May 28, 2023 7,241 Disposed
Feb. 13, 2023 MCD Options (Right to Buy) Common Stock (24,840) $266.20 Feb. 13, 2033 24,840 Acquired
Feb. 13, 2023 MCD Restricted Stock Units Common Stock · May 28, 2023 2,999 Acquired
May 28, 2022 MCD Restricted Stock Units Common Stock (10,597) · · 10,597 Disposed
May 28, 2022 MCD Dividend Equivalent Rights Common Stock (497) · · 497 Disposed
May 28, 2022 MCD Restricted Stock Units Common Stock (6,624) · · 6,624 Disposed
May 28, 2022 MCD Dividend Equivalent Rights Common Stock (311) · · 311 Disposed
Feb. 14, 2022 MCD Options (Right to Buy) Common Stock (30,865) $253.39 Feb. 14, 2032 30,865 Acquired
May 28, 2021 MCD Restricted Stock Units Common Stock (10,598) · · 10,598 Disposed
May 28, 2021 MCD Dividend Equivalent Rights Common Stock (257) · · 257 Disposed
Feb. 16, 2021 MCD Options (Right to Buy) Common Stock (48,528) $215.03 Feb. 16, 2031 48,528 Acquired
May 28, 2020 MCD Options (Right to Buy) Common Stock (37,009) $188.73 May 28, 2030 37,009 Acquired
May 28, 2020 MCD Restricted Stock Units Common Stock (4,711) · May 28, 2023 4,711 Acquired
May 28, 2020 MCD Restricted Stock Units Common Stock (21,195) · May 28, 2022 21,195 Acquired
May 28, 2020 MCD Restricted Stock Units Common Stock (13,247) · May 28, 2024 13,247 Acquired
Feb. 13, 2019 BA Stock Option (Right to Buy) Common Stock (2,916) $75.96 Feb. 25, 2023 2,916 Disposed
July 31, 2017 BA Stock Option (Right to Buy) Common Stock (1,346) $75.40 Feb. 27, 2022 1,346 Disposed

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 5 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Oct. 14, 2025 CVS Common Stock · Indirect
Dec. 22, 2015 BA Common Stock · Direct
Dec. 22, 2015 BA Common Stock 112 Indirect
Dec. 22, 2015 BA Stock Option (Right to Buy)→ Common Stock (1,346) 1,346 Direct
Dec. 22, 2015 BA Stock Option (Right to Buy)→ Common Stock (2,916) 2,916 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

CVS

Chief People Officer
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2024 $265,625 $1,500,000 · · · · $85,134 $6,850,748

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.